BSE Code : 500680 NSE Code : PFIZER Sector : PHARMACEUTICALS Report date : Thu Apr 24 06:48:34 EDT 2014 Industry overview Market Cap Market Cap is the price of all the outstanding common shares if we were to buy it all at the current price 3725.11 Cr The benchmark company Sun Pharma in the pharmaceuticals sector is 35 times the size of Pfizer Mid Caps are a choice for people who can take medium volatility/risk with higher chance of returns 1
Pfizer
Nov 13, 2014
A financial fundamental analysis of the pharma company . This covers the growth analysis and piotroski analysis to identify accounting strength. More details can be found in the paid version of the report. Lots more @ goodinvestory.com
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
BSE Code : 500680
NSE Code : PFIZER
Sector : PHARMACEUTICALSReport date : Thu Apr 24 06:48:34 EDT 2014
Industry overview
Market CapMarket Cap is the price ofall the outstandingcommon shares if we wereto buy it all at the currentprice
3725.11 Cr
The benchmark companySun Pharma in thepharmaceuticals sector is35 times the size of Pfizer
Mid Caps are a choice forpeople who can takemedium volatility/risk withhigher chance of returns
1
Stock AnalysisGrowth Analysis
Companies that have grown historically are more likely to exibit similar growth in the future. Read
the trends in the 4 year annualized profit growth, book value growth and sales growth shown
below:
How good are the returns?
RoE is the speed at which the company might grow without sorting to additional fund raising.
RoCE is the growth speed, if the company used all the assets, including loans/preference shares.
The 2-year and 4-year values give a reasonable assurance about the growth sustenance.
KEY
KEY
2
Piotroski ScoreSeperate Winners from Losers
The Piotroski scoring system is a nine point system to determine the strength of a firm's financial
position. The score was developed by an accounting professor out of Chicago named Joseph
Piotroski. If it scores an 8 or 9, then the fundamentals are great for the stock.
Score: 4/9
3
DISCLAIMER
This report is prepared by the good.inve.story. software and is not prepared by an
actual person who has a CFA or any other certification.
good.inve.story. is still in BETA mode. So, please let us know if you find any errors.
We would love to hear from you.
This report is based on information obtained from public sources and sources
believed to be reliable, but no independent verification has been made nor is its
accuracy or completeness guaranteed.
This report is not an advisory to buy or sell. Please buy only if you think, this is the
right company at the right price and sell only if you don’t see any potential for
upside.
get more @ goodinvestory.com
4
Related Documents
